Routine 18F-FDG PET preoperative staging of colorectal cancer: Comparison with conventional staging and its impact on treatment decision making

Journal of Nuclear Medicine

Volumn 44, Issue 11, 2003, Pages 1784-1788

  Kantorová, Iva ^a,b   Lipská, Ludmila ^b   Bělohlávek, Otakar ^a   Visokai, Vladimír ^b   Trubač, Miroslav ^b   Schneiderová, Michaela ^b  

^a NA HOMOLCE HOSPITAL   (Czech Republic)

^b Thomayer's University Hospital   (Czech Republic)

Author keywords

18F FDG; Colorectal cancer; PET; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ARTICLE; CANCER STAGING; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; HISTOLOGY; HUMAN; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY; ADULT; AGED; COLORECTAL TUMOR; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; SCINTISCANNING;

ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0642284539     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Klener P, Zaloudik J. Tumors of GIT [in Czech]. In: Klener P, ed. Clinical Oncology [in Czech]. Prague, Czech Republic: Galěn; 2002:397-415.
2. Cohen AM, Minsky BD, Schilsky RL. Cancer of the colon. In: DeVita VT Jr. Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology Philadelphia, PA: Lippincott-Raven Publishers; 1997:1144-1195.
3. Reske SN, Kotzerke J FDG-PET for clinical use. Eur J Nucl Med. 2001;28:1707-1723.
4. Boykin KN, Ziban GB, Lilien DL, McMillan RW, Aultman DF, McDonald JC. The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver. Am Surg. 1999;65:1183-1185.
5. Topal B, Flamen P, Aerts R, et al. Clinical value of whole-body emission tomography in potentially curable colorectal liver metastases. Eur J Surg Oncol 2001;27:175-179.
6. Rohren EM, Paulson EK, Hagge R, et al The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer. Clin Nucl Med. 2002;27:550-555.
7. Ruers TJ, Langenhoff BS, Neeleman N, et al. Value of positron emission tomography with (F-18)fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol. 2002;20:388-395.
8. 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg. 1999;178:282-287
9. Whiteford MH, Whiteford HM, Yee LF, et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum. 2000;43:759-767.
10. Ogunbiyi OA, Flanagan FL, Dehdashti F, et al. Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography Ann Surg Oncol 1997;4:613-620.
11. Abdel-Nabi H, Doerr RJ, Lamonica DM, et al. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology. 1998;206:755-760
12. 18F-fluorodeoxyglucose positron emission tomography in patients with primary colorectal cancer. Oncol Rep. 2000;7:85-87
13. Gupta NC, Falk PM, Frank AL, Thorson AM, Frick MP, Bowman B. Pre-operative staging of colorectal carcinoma using positron emission tomography Nebr Med J. 1993;78:30-35.
14. Zhuang H, Sinha P, Pourdehnad M, Duarte PS, Yamamoto AJ, Alavi A. The role of positron emission tomography with fluorine-18-deoxyglucose in identifying colorectal cancer metastases to liver. Nucl Med Commun. 2000;21:793-798